Few U.S. States Mandate Human Papillomavirus Vaccine
Immunization protects against sexually transmitted disease, certain cancers, health experts say
ASCO Updates Guidelines for Colony-Stimulating Factor Use
Special article updates 2006 guidelines, including addition of tbo-filgrastim and filgrastim-sndz
Uncontrolled Diabetes Linked to Increased Risk of Dementia
Older patients with more disease complications have greater cognitive decline
Alcohol Use Appears to Impair Driving More Than Cannabis Use
And combination of the two increases risks but effect isn't doubled
Multiple Contraceptive Attributes Influence Decision Making
Highest importance scores for effectiveness, safety, affordability, whether method is long lasting
Strategies Needed to Combat Weight Gain in Smoking Cessation
Considerably greater weight gain seen in North American versus Asian studies
Coronary Artery Disease Ups Risk of Bowel Bleeds With NSAIDs
Co-use of thienopyridine and prior use of rebamipide also up risk
Metformin in Pregnancy Shows No Effect on Infant Birth Weight
However, metformin can help to control women's blood glucose, researchers find
FDA Approves Rexulti for Schizophrenia, Depression
But shouldn't be prescribed to some older people
![Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer with a specific genetic mutation (epidermal growth factor receptor [EGFR]). A just-approved companion diagnostic test can identify patients who could benefit from this new use.](https://www.ehealth-news.com/wp-content/uploads/2016/01/fdalogo-6-180x84.jpg "FDA Approves Iressa for EGFR+ Metastatic Lung Cancer")
FDA Approves Iressa for EGFR+ Metastatic Lung Cancer
New companion diagnostic kit can identify candidates
